tetano
Editor, Senior Moderator
Diagn Interv Imaging
. 2021 Jul 13;S2211-5684(21)00169-8.
doi: 10.1016/j.diii.2021.06.007. Online ahead of print.
Association between coronary artery calcifications and 6-month mortality in hospitalized patients with COVID-19
Elie Mousseaux[SUP] 1 [/SUP], Antoine Fayol[SUP] 2 [/SUP], Nicolas Danchin[SUP] 3 [/SUP], Gilles Soulat[SUP] 4 [/SUP], Etienne Charpentier[SUP] 5 [/SUP], Marine Livrozet[SUP] 6 [/SUP], Jean-Baptiste Carves[SUP] 6 [/SUP], Victoria Tea[SUP] 7 [/SUP], Fares Ben Salem[SUP] 5 [/SUP], Chekrallah Chamandi[SUP] 7 [/SUP], Jean-Sébastien Hulot[SUP] 2 [/SUP], Etienne Puymirat[SUP] 8 [/SUP]
Affiliations
Abstract
Purpose: The purpose of this study was to evaluate the association between coronary artery calcium (CAC) visual score and 6-month mortality in patients with coronavirus disease 2019 (COVID-19).
Material and methods: A single-center prospective observational cohort was conducted in 169 COVID-19 consecutive hospitalized patients between March 13 and April 1, 2020, and follow-up for 6-months. A four-level visual CAC scoring was assessed by analyzing images obtained after the first routine non-ECG-gated CT performed to detect COVID-19 pneumonia.
Results: Among 169 confirmed COVID-19 patients (118 men, 51 women; mean age, 65.6 ± 18.8 [SD] years; age range: 30-95 years) 63 (37%) presented with either moderate (n = 26, 15.3%) or heavy (n = 37, 21.8%) CAC detected by CT and 20 (11.8%) had history of cardiovascular disease requiring specific preventive treatment. At six months, mortality rate (45/169; 26.6%) increased with magnitude of CAC and was 7/64 (10.9%), 11/42 (26.2%), 10/26 (38.5%), 17/37 (45.9%) for no-CAC, mild-CAC, moderate-CAC and heavy-CAC groups, respectively (P = 0.001). Compared to the no CAC group, risk of death increased after adjustment with magnitude of CAC (HR: 2.23, 95% CI: 0.73-6.87, P = 0.16; HR: 2.78, 95% CI: 0.85-9.07, P0.09; HR: 5.38, 95% CI: 1.57-18.40, P = 0.007; in mild CAC, moderate and heavy CAC groups, respectively). In patients without previous coronary artery disease (154/169; 91%), mortality increased from 10.9% to 45.8% (P = 0.001) according to the magnitude of CAC categories. After adjustment, presence of moderate or heavy CAC was associated with higher mortality (HR: 2.26, 95% CI: 1.09-4.69, P = 0.03).
Conclusion: By using non-ECG-gated CT during the initial pulmonary assessment of COVID-19, heavy CAC is independently associated with 6-month mortality in patients hospitalized for severe COVID-19 pneumonia.
Keywords: COVID-19; Computed tomography; Coronary artery calcification; Myocardial injury; Outcomes.
. 2021 Jul 13;S2211-5684(21)00169-8.
doi: 10.1016/j.diii.2021.06.007. Online ahead of print.
Association between coronary artery calcifications and 6-month mortality in hospitalized patients with COVID-19
Elie Mousseaux[SUP] 1 [/SUP], Antoine Fayol[SUP] 2 [/SUP], Nicolas Danchin[SUP] 3 [/SUP], Gilles Soulat[SUP] 4 [/SUP], Etienne Charpentier[SUP] 5 [/SUP], Marine Livrozet[SUP] 6 [/SUP], Jean-Baptiste Carves[SUP] 6 [/SUP], Victoria Tea[SUP] 7 [/SUP], Fares Ben Salem[SUP] 5 [/SUP], Chekrallah Chamandi[SUP] 7 [/SUP], Jean-Sébastien Hulot[SUP] 2 [/SUP], Etienne Puymirat[SUP] 8 [/SUP]
Affiliations
- PMID: 34312110
- DOI: 10.1016/j.diii.2021.06.007
Abstract
Purpose: The purpose of this study was to evaluate the association between coronary artery calcium (CAC) visual score and 6-month mortality in patients with coronavirus disease 2019 (COVID-19).
Material and methods: A single-center prospective observational cohort was conducted in 169 COVID-19 consecutive hospitalized patients between March 13 and April 1, 2020, and follow-up for 6-months. A four-level visual CAC scoring was assessed by analyzing images obtained after the first routine non-ECG-gated CT performed to detect COVID-19 pneumonia.
Results: Among 169 confirmed COVID-19 patients (118 men, 51 women; mean age, 65.6 ± 18.8 [SD] years; age range: 30-95 years) 63 (37%) presented with either moderate (n = 26, 15.3%) or heavy (n = 37, 21.8%) CAC detected by CT and 20 (11.8%) had history of cardiovascular disease requiring specific preventive treatment. At six months, mortality rate (45/169; 26.6%) increased with magnitude of CAC and was 7/64 (10.9%), 11/42 (26.2%), 10/26 (38.5%), 17/37 (45.9%) for no-CAC, mild-CAC, moderate-CAC and heavy-CAC groups, respectively (P = 0.001). Compared to the no CAC group, risk of death increased after adjustment with magnitude of CAC (HR: 2.23, 95% CI: 0.73-6.87, P = 0.16; HR: 2.78, 95% CI: 0.85-9.07, P0.09; HR: 5.38, 95% CI: 1.57-18.40, P = 0.007; in mild CAC, moderate and heavy CAC groups, respectively). In patients without previous coronary artery disease (154/169; 91%), mortality increased from 10.9% to 45.8% (P = 0.001) according to the magnitude of CAC categories. After adjustment, presence of moderate or heavy CAC was associated with higher mortality (HR: 2.26, 95% CI: 1.09-4.69, P = 0.03).
Conclusion: By using non-ECG-gated CT during the initial pulmonary assessment of COVID-19, heavy CAC is independently associated with 6-month mortality in patients hospitalized for severe COVID-19 pneumonia.
Keywords: COVID-19; Computed tomography; Coronary artery calcification; Myocardial injury; Outcomes.